Keywords : Candida scoring systems, candidemia, Intensive Care Unit
Citation Information :
Gupta P, Gupta P, Chatterjee B, Mittal G, Prateek S, Mohanty A. Evaluation of Candida scoring systems to predict early candidemia: A prospective and observational study at a tertiary care hospital, Uttarakhand. Indian J Crit Care Med 2017; 21 (12):830-835.
Background: Candidemia in critically ill patients is usually a severe and life-threatening condition. Furthermore, due to its nonspecific presentation, it is difficult to diagnose leading to delayed treatment, prolonged hospitalization, and increased health-care costs with increase in morbidity and mortality.
Objectives: In view of lack of data on “Candida scoring systems,” this study was designed to evaluate the effectiveness of these scoring systems in predicting the development of candidemia among the Intensive Care Unit patients.
Materials and Methods: The “Candida score” was calculated at the onset of systemic inflammatory response syndrome, sepsis, or shock. Various scoring systems were compared using the area under the receiver operating characteristic curve.
Results: Among all three bedside risk scoring systems to predict candidemia both Leon score and Wenzel score offered significant discrimination between candidemic and noncandidemic patients with P = 0.000 and 0.001, respectively. The area under the curve for the scoring systems was 0.946 (95% confidence interval [CI] = 0.89–1) and 0.818 (95% CI = 0.687–0.949).
Conclusion: Leon scoring system was found to have highest specificity, diagnostic accuracy, and positive likelihood ratio among all. Thus, we might conclude that a Leon score of ≥2.5 was most suitable for diagnosis of candidemia with significant accuracy and shortening of turnaround time when compared to the gold standard of blood culture. To the best of our knowledge, this is the first report on the subject.
Lamagni TL, Evans BG, Shigematsu M, Johnson EM. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001;126:397-414.
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB, et al. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in Intensive Care Units: Analysis of the extended prevalence of infection in Intensive Care Unit study. Crit Care Med 2011;39:665-70.
Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis 2004;38:311-20.
Voss A, le Noble JL, Verduyn Lunel FM, Foudraine NA, Meis JF. Candidemia in Intensive Care Unit patients: Risk factors for mortality. Infection 1997;25:8-11.
Chen YC, Lin SF, Liu CJ, Jiang DD, Yang PC, Chang SC, et al. Risk factors for ICU mortality in critically ill patients. J Formos Med Assoc 2001;100:656-61.
Verma AK, Prasad KN, Singh M, Dixit AK, Ayyagari A. Candidemia in patients of a tertiary health care hospital from North India. Indian J Med Res 2003;117:122-8.
Nolla-Salas J, Sitges-Serra A, León-Gil C, Martínez-González J, León-Regidor MA, Ibáñez-Lucía P, et al. Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 1997;23:23-30.
Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for Candidal infections in the surgical Intensive Care Unit: Approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005;43:235-43.
León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006;34:730-7.
Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version. Available from: http://www.openEpi.com. [Last updated on 2013 Apr 06; Last accessed on 2014 Aug 20].
Shorr AF, Tabak YP, Johannes RS, Sun X, Spalding J, Kollef MH, et al. Candidemia on presentation to the hospital: Development and validation of a risk score. Crit Care 2009;13:R156.
Leroy G, Lambiotte F, Thévenin D, Lemaire C, Parmentier E, Devos P, et al. Evaluation of “Candida score” in critically ill patients: A prospective, multicenter, observational, cohort study. Ann Intensive Care 2011;1:50.
Bassetti M, Mikulska M, Viscoli C. Bench-to-bedside review: Therapeutic management of invasive candidiasis in the Intensive Care Unit. Crit Care 2010;14:244.
Resende JC, de Resende MA, Saliba JL. Prevalence of Candida spp. In hospitalized patients and their risk factors. Mycoses 2002;45:306-12.
Chowta MN, Adhikari P, Rajeev A, Shenoy AK. Study of risk factors and prevalence of invasive candidiasis in a Tertiary care hospital. Indian J Crit Care Med 2007;11:67-73.
Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of North India: 5-year study. Infection 2007;35:256-9.
González de Molina FJ, León C, Ruiz-Santana S, Saavedra P; CAVA I Study Group. Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit Care 2012;16:R105.
Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, et al. Risk factors for Candidal bloodstream infections in surgical Intensive Care Unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001;33:177-86.